Conditions 8 min read Updated September 22, 2026

Neuropathy and Regenerative Medicine: What the 2025-2026 Evidence Shows for Nerve Pain

P Written by: Phil Kim Medically reviewed by: Dr. Robert Aki, DPM Last medically reviewed: September 22, 2026
An anatomical model of a foot and lower leg with visible nerve pathways on a white counter in a bright Honolulu consultation room

Peripheral neuropathy, the numbness, tingling, burning, or shooting pain that often starts in the feet, is one of the most common nerve problems patients bring to a regenerative medicine clinic. Research on treating it with PRP and stem cells has grown quickly in 2025 and 2026, but the evidence is still young. This article sorts through what the newest studies show, what remains experimental, and what that honestly means for someone considering care in Honolulu.

12

randomized trials in a 2025 systematic review of PRP for neuropathic pain

80

patients in a 2025 case-control study of PRP for diabetic neuropathy

+2.2

motor nerve conduction velocity gain (m/s) in a stem-cell neuropathy meta-analysis

What peripheral neuropathy actually is

Peripheral neuropathy is damage or dysfunction of the nerves outside the brain and spinal cord, most often felt in the hands and feet. The symptoms are familiar: tingling, numbness, burning, or sharp pain that can be worse at night. The most common cause worldwide is diabetes, but neuropathy can also come from nerve compression, vitamin deficiencies, thyroid problems, certain medications, alcohol use, and injuries. That list matters, because the right treatment depends on the cause, and because some causes are reversible while others are not.

Why neuropathy deserves a careful Honolulu conversation

In Honolulu, neuropathy shows up in people of all ages and activity levels, from surfers and paddlers with years of saltwater and repetitive strain, to retirees managing diabetes, to workers who stand all day. Many people assume the tingling is just part of getting older. Sometimes it is, and sometimes it is a sign of something treatable. Because foot and ankle symptoms are so common, a clinician with foot and ankle expertise, like Dr. Robert Aki, DPM on our team, can help separate nerve problems from tendon, joint, or circulation issues that feel similar.

PRP for neuropathy: what the newest studies show

Platelet-rich plasma has become one of the most studied regenerative options for nerve pain. A 2025 systematic review of 12 randomized trials concluded that most studies suggest PRP is effective for relieving neuropathic pain with no serious complications, though the authors could not pool the results into a formal meta-analysis because the trials were too different in design, and they flagged methodological limitations. A 2025 case-control study of 80 patients with diabetic peripheral neuropathy found that ultrasound-guided perineural PRP injections, combined with standard medical treatment, significantly reduced symptoms and supported nerve function. A 2026 randomized-trial report likewise showed perineural PRP significantly reduced pain and numbness at 1, 3, and 6 months and improved nerve conduction. The consistent caveat: these are encouraging but small, early human studies, not proof.

“A 2025 systematic review of 12 randomized trials found most studies suggest PRP relieves neuropathic pain without serious complications, but results could not be formally pooled due to heterogeneity and methodological limitations.”

Stem cells for diabetic neuropathy: the meta-analysis evidence

The strongest pooled evidence on stem cells for neuropathy comes from diabetic peripheral neuropathy, the most common form. A meta-analysis in Stem Cell Research and Therapy covering 7 controlled trials and roughly 400 patients with diabetic neuropathy found that stem cell therapy significantly improved motor nerve conduction velocity by about 2.2 meters per second and sensory nerve conduction velocity by about 1.9 meters per second, while also improving vibration perception and clinical neuropathy scores. The authors described the results as showing significant promise while calling for larger, better-designed trials and standardized protocols. In plain terms, the signals are real but the treatment is not ready to be called standard care.

“A meta-analysis of 7 controlled trials and about 400 patients with diabetic neuropathy found stem cell therapy significantly improved motor and sensory nerve conduction velocity, with the authors urging larger trials and protocol standardization.”

Systematic review and meta-analysis, Stem Cell Research & Therapy (2024)

Read the source

The honest limits: experimental, not standard

Every credible review of this field says the same thing: much of the basic science on regenerative treatments for nerve repair comes from animal and laboratory models, and the human evidence base remains small and varied. No stem cell product is FDA approved for neuropathy, and no clinic can honestly present PRP or cell therapy for nerve pain as an established cure. A trustworthy approach treats regenerative options as one part of a plan that starts with a real diagnosis, addresses the underlying cause where possible, and sets expectations that improvement, when it comes, is gradual and partial for many people.

What this means for you in Honolulu

If you are dealing with persistent tingling, numbness, or burning in your feet or hands, the right first step is not an injection, it is an evaluation that identifies what is actually driving the symptoms. Blood work, a careful exam, and sometimes nerve studies can find causes that are highly treatable without any regenerative therapy. If a regenerative treatment is then worth discussing, it should be chosen for a specific reason, with honest evidence, and alongside the basics that protect nerves over time: blood sugar control when relevant, good footwear, activity, and nutrition.

Questions to ask

  • What is the actual cause of my symptoms, and has it been confirmed with testing?
  • Is my neuropathy primarily type 2 diabetes related, compressive, or from another cause?
  • What conventional and conservative options should come first?
  • If PRP or cell therapy is discussed, what does the evidence show for my specific situation, and is it strong or still early?
  • How will we measure progress, and over what realistic timeline?

A note from the clinic

Nerve pain deserves a careful diagnosis before any treatment is discussed, and our foot and ankle expertise means we are well equipped to help you get one. At Aloha Stem Cell in Honolulu we will listen to your symptoms, explain what the 2025 and 2026 research does and does not support, and be honest about whether a regenerative option fits your situation. Call (808) 593-2525 to start the conversation.

Want to talk through your own situation?

Our team is happy to listen to your story, answer your questions, and help you decide whether a consultation makes sense. There is no pressure and no obligation.

Keep reading

More from the library

Browse all articles
A researcher in a white lab coat adjusting a laboratory microscope while a softly glowing brain scan sits on a monitor behind, in a calm clinical research setting
Science Oct 9, 2026

Cell Therapy for ALS and Parkinson's: The 2026 Trial Updates

In September 2026 the FDA granted Fast Track status to an experimental cell therapy for ALS, and in August researchers presented new Phase 1/2 data on a stem cell therapy for Parkinson's. Both are real advances and both remain investigational. Here is the honest read.

6 min read Read article

Book a consultation

Request an appointment

Pick a time that works for you and our team will confirm your consultation. Questions first? Call us anytime at (808) 593-2525.